[2O07m-2] Dementia 2

Wed. Aug 2, 2023 9:45 AM - 10:45 AM Room 7 (Shirakashi 2)

Chair: Taisuke Tomita (Graduate School of Pharmaceutical Sciences, The University of Tokyo), Makoto Higuchi (National Institutes for Quantum Science and Technology)

+Add all to schedule

[2O07m-2-01] Establishment of the In Vitro Models of Alzheimer’s Disease Patients Using iPSCs and the Evaluation of Sex Hormone’s Effects

○Sopak Supakul¹, Sumihiro Maeda¹, Hideyuki Okano¹ (1. Sch Med, Keio Univ, Tokyo, Japan)

[2O07m-2-02] Beta-alanyl-3-methyl-L-histidine prevents tau-mediated neurodegeneration and cognitive decline by inhibiting astrocytes activation via NF-kB signaling pathway

○CHENXU LEI¹, Tatsuhiro Hisatsune¹ (1. Graduate School of Frontier Sciences, The University of Tokyo)

[2O07m-2-03] Analyses of Apolipoprotein E Christchurch variant of iPS cell-derived astrocytes in Alzheimer's disease

○Rei Murakami¹, Hirotaka Watanabe¹, Hideyuki Okano¹ (1. Keio University School of Medicine, Tokyo, Japan)

[2O07m-2-04] Neuroinflammatory and cognitive profiles with aging in a transgenic model of Alzheimer’s disease

○AVIJIT BANIK^1,2, Thota Ganesh² (1. Current address: Department of Biotechnology, School of Science, GITAM (Deemed to be) University, Visakhapatnam, AP, 530025, India, 2. Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, 30322, USA)

Session information